Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 43 | $12,923,521 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Mar 2025 | Sale | 8,201 | 44.697 | 366,560 | D |
| 18 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Mar 2025 | Sale | 1,799 | 45.05 | 81,045 | D |
| 14 Mar 2025 20:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Mar 2025 | Sale | 614 | 44.88 | 27,556 | D |
| 21 Feb 2025 17:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Feb 2025 | Sale | 9,100 | 49.79 | 453,089 | D |
| 21 Feb 2025 17:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Feb 2025 | Sale | 900 | 50.634 | 45,571 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 17,000 | 55.156 | 937,652 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 9,250 | 55.949 | 517,528 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 27,340 | 57.024 | 1,559,036 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 25,907 | 55.152 | 1,428,823 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 14,467 | 55.95 | 809,429 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 8,700 | 57.007 | 495,961 | D |
| 18 Dec 2024 21:01 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Dec 2024 | Sale | 9,074 | 29.107 | 264,117 | D |
| 12 Dec 2024 20:28 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Dec 2024 | Sale | 2,810 | 30.79 | 86,520 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 8,761 | 27.694 | 242,627 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 300 | 28.823 | 8,647 | D |
| 08 Nov 2024 17:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 06 Nov 2024 | Sale | 10,000 | 35.189 | 351,890 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 30 Oct 2024 | Sale | 4,515 | 32.526 | 146,855 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 01 Nov 2024 | Sale | 15,485 | 32.619 | 505,105 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 14,525 | 30.496 | 442,954 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 300 | 30.927 | 9,278 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Oct 2024 | Sale | 6,136 | 30.029 | 184,258 | D |
| 23 Sep 2024 18:00 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 20 Sep 2024 | Sale | 5,500 | 27.652 | 152,086 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Sep 2024 | Sale | 3,871 | 27.56 | 106,685 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Sep 2024 | Sale | 2,037 | 27.548 | 56,115 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Sep 2024 | Sale | 2,485 | 27.515 | 68,375 | D |
| 13 Sep 2024 17:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Sep 2024 | Sale | 637 | 26.18 | 16,677 | D |
| 05 Sep 2024 16:05 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 03 Sep 2024 | Sale | 949 | 27.614 | 26,206 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 26 Aug 2024 | Sale | 5,200 | 27.514 | 143,073 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Aug 2024 | Sale | 8,851 | 27.527 | 243,641 | D |
| 13 Jun 2024 18:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 11 Jun 2024 | Sale | 2,825 | 22.641 | 63,961 | D |
| 15 Mar 2024 16:45 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Mar 2024 | Sale | 723 | 28.33 | 20,483 | D |
| 06 Mar 2024 20:13 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 04 Mar 2024 | Sale | 20,646 | 35.49 | 732,727 | D |
| 18 Dec 2023 20:49 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Dec 2023 | Sale | 597 | 20.76 | 12,394 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,200 | 48.3577 | 106,387 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,800 | 47.8461 | 133,969 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2023 | Sale | 617 | 50.34 | 31,060 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 500 | 50.67 | 25,335 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 5,245 | 49.9248 | 261,856 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 500 | 51.4087 | 25,704 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 10,500 | 50.7291 | 532,656 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 22 Jun 2023 | Sale | 11,000 | 52.1759 | 573,935 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Jun 2023 | Sale | 11,349 | 52.2597 | 593,095 | D |
| 15 Jun 2023 21:29 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jun 2023 | Sale | 591 | 55.16 | 32,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)